Intra-Cellular Therapies Inc. buy melinda
Start price
30.08.17
/
50%
€18.13
Target price
27.12.17
€25.00
Performance (%)
-14.01%
End price
27.12.17
€15.59
Summary
This prediction ended on 27.12.17 with a price of €15.59. The prediction for Intra-Cellular Therapies Inc. disappointed with a performance of -14.01%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Intra-Cellular Therapies Inc. | 0.000% | 0.000% | 32.554% | 110.526% |
iShares Core DAX® | 0.936% | 1.535% | 21.949% | 19.324% |
iShares Nasdaq 100 | 3.064% | 1.968% | 29.275% | 38.772% |
iShares Nikkei 225® | 1.898% | -0.295% | 14.740% | 1.986% |
iShares S&P 500 | 1.653% | 2.318% | 27.064% | 40.403% |
Comments by melinda for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
ITCI auf dem richtigen Weg für die Einreichung der NDA bis Mitte 2018
(Vom Mitglied beendet)
Stopped prediction by melinda for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€11.81
04.04.19
04.04.19
€18.04
04.11.21
04.11.21
233.36%
05.11.21
05.11.21
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€16.35
30.08.17
30.08.17
€22.55
27.12.17
27.12.17
-14.01%
27.12.17
27.12.17